Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Michael Horton

2106 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News

DoorDash Activates Severe Weather Protocol Due To Hurricane Ian, Says Will Suspend All Operations In Tampa, Miami, Orlando, Fort Myers From 9:00 p.m. EDT Tuesday, Sept. 27

By Michael Horton
September 27, 5:19 PM
-Reuters

DASH

Read More
1 minute read
  • News

CFTC Says Nomura To Pay $50M In Penalty, Jefferies To Pay $30M, Cantor Fitzgerald To Pay $6M

By Michael Horton
September 27, 5:18 PM
-Reuters

JEF

Read More
1 minute read
  • News

CFTC Orders 11 Financial Institutions To Pay Over $710M For Recordkeeping, Supervision Failures For Widespread Use Of Unapproved Communication Methods

By Michael Horton
September 27, 5:16 PM
-Reuters

BAC

Read More
1 minute read
  • News

UPDATE: PhaseBio Pharmaceuticals Says SFJ Demanding That Co. Execute Program Transfer Agreement Within Ten Days Following Delivery Of Program Transfer Notice, Says Board Is Considering All Potential Actions In Response To Program Transfer Notice

By Michael Horton
September 27, 5:11 PM
-Reuters

PHAS

Read More
1 minute read
  • News

PhaseBio Pharmaceuticals Says On Sept. 21, Co. Received Program Transfer Notice From SFJ Pharmaceuticals, Says Notice Notifying Co. That SFJ Has Elected To Cause Company’s Business Related To Bentracimab To Be Transferred To SFJ

By Michael Horton
September 27, 5:10 PM
-Reuters

PHAS

Read More
1 minute read
  • Earnings
  • News

BlackBerry Q2 EPS $(0.05) Beats $(0.07) Estimate, Sales $168.00M Miss $177.25M Estimate

By Michael Horton
September 27, 5:05 PM
BlackBerry (NYSE:BB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 16.67 percent increase over losses of $(0.06) per share from the same

BB

Read More
1 minute read
  • News
  • Offerings

MFA Financial Files For Mixed-Securities Shelf Offering, Size Not Disclosed

By Michael Horton
September 27, 5:03 PM
-Reuters

MFA

Read More
3 minute read
  • Cannabis
  • Markets
  • News

Canopy Growth Announces Divestiture of Canadian Retail Operations

By Michael Horton
September 27, 4:51 PM
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) announced today that the Company has entered into agreements to divest its retail business

CGC

Read More
1 minute read
  • FDA
  • News

Thermo Fisher Scientific Announces FDA Approval Of Oncomine Dx Target Test As First NGS-Based Companion Diagnostic To Aid In Therapy Selection For Patients With RET Mutations/Fusions In Thyroid Cancer

By Michael Horton
September 27, 4:33 PM
-Reuters

TMO

Read More
1 minute read
  • News
  • Offerings

Gamida Cell Announces Launch of Public Offering of Ordinary Shares, Size Not Disclosed

By Michael Horton
September 27, 4:07 PM
Gamida Cell Ltd. (NASDAQ:GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the launch of a follow-on

GMDA

Posts pagination

Previous 1 … 148 149 150 … 211 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service